Search research articles
Contact Us
Filters
Showing results (121-130 of 216) with videos related to
Page
of 22
Sort By:
Oncogene
|
August 6, 1998
Tumor promoter induces high mobility group HMG-Y protein expression in transformation-sensitive but not -resistant cells
J L Cmarik, Y Li, S A Ogram, et al.
Oncogene
|
February 14, 2007
Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors
J H Leupold, H-S Yang, N H Colburn, et al.
Science (New York, N.Y.)
|
October 21, 2006
S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth
N Valerio Dorrello, Angelo Peschiaroli, Daniele Guardavaccaro, et al.
RNA (New York, N.Y.)
|
January 22, 2005
Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI
Halina Zakowicz, Hsin-Sheng Yang, Cristi Stark, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 26, 2009
JNK/AP-1 pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells
Yongmei Yin, Shui Wang, Yujie Sun, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 1, 1992
The presence in a mouse T cell line of a 97-kDa protein kinase C (PKC) with characteristics similar to known members of the novel PKC subgroup and its possible role in lymphocyte gene expression
S L Simek, A P Fields, N H Colburn, et al.
Carcinogenesis
|
May 6, 2009
Linoleic acid metabolite suppresses skin inflammation and tumor promotion in mice: possible roles of programmed cell death 4 induction
Michiko Yasuda, Takashi Nishizawa, Hajime Ohigashi, et al.
Molecular Cancer Therapeutics
|
January 7, 2004
Nitric oxide does not mediate but inhibits transformation and tumor phenotype
Arindam Dhar, June M Brindley, Cristi Stark, et al.
Oncogene
|
November 4, 2008
Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53
J Kitagaki, Y Yang, J E Saavedra, et al.
Cancer Research
|
February 26, 2008
Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion
Tobias Schmid, Aaron P Jansen, Alyson R Baker, et al.
Page
of 22
Search research articles
Search
Showing results (121-130 of 216) with videos related to
Sort By:
Page
of 22
Oncogene
|
August 6, 1998
Tumor promoter induces high mobility group HMG-Y protein expression in transformation-sensitive but not -resistant cells
J L Cmarik, Y Li, S A Ogram, et al.
Oncogene
|
February 14, 2007
Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors
J H Leupold, H-S Yang, N H Colburn, et al.
Science (New York, N.Y.)
|
October 21, 2006
S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth
N Valerio Dorrello, Angelo Peschiaroli, Daniele Guardavaccaro, et al.
RNA (New York, N.Y.)
|
January 22, 2005
Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI
Halina Zakowicz, Hsin-Sheng Yang, Cristi Stark, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 26, 2009
JNK/AP-1 pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells
Yongmei Yin, Shui Wang, Yujie Sun, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 1, 1992
The presence in a mouse T cell line of a 97-kDa protein kinase C (PKC) with characteristics similar to known members of the novel PKC subgroup and its possible role in lymphocyte gene expression
S L Simek, A P Fields, N H Colburn, et al.
Carcinogenesis
|
May 6, 2009
Linoleic acid metabolite suppresses skin inflammation and tumor promotion in mice: possible roles of programmed cell death 4 induction
Michiko Yasuda, Takashi Nishizawa, Hajime Ohigashi, et al.
Molecular Cancer Therapeutics
|
January 7, 2004
Nitric oxide does not mediate but inhibits transformation and tumor phenotype
Arindam Dhar, June M Brindley, Cristi Stark, et al.
Oncogene
|
November 4, 2008
Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53
J Kitagaki, Y Yang, J E Saavedra, et al.
Cancer Research
|
February 26, 2008
Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion
Tobias Schmid, Aaron P Jansen, Alyson R Baker, et al.
Page
of 22